Telehealth
Telehealth

DEA Issues Third Extension of Temporary Telemedicine Flexibilities
The U.S. Drug Enforcement Administration (DEA) has extended the temporary telemedicine flexibilities allowing providers to prescribe controlled substances without an…
Health News

FDA Outlines AI-Driven Reforms to Accelerate Drug Development
In a recent JAMA article, the FDA outlined its priorities to address delays in the drug approval process, including the…